Literature DB >> 213852

Preoperative and follow-up bone scans in patients with primary carcinoma of the breast.

B J McNeil, P D Pace, E B Gray, S J Adelstein, R E Wilson.   

Abstract

We have attempted to evaluate the role of preoperative and postoperative bone scans in patients with localized carcinoma of the breast. The yield of positive preoperative scans in patients with Stages I and II disease is low and confounded by a relatively high percentage of false-positive results. Conversely, 16 per cent of patients with Stage III disease had evidence of bony metastasis at the time of operation. Positive bone scans were found three times as frequently in patients with axillary node involvement than in those without. Thirty per cent of those observed for varying times up to 41 months had evidence of bony metastases. Again, there was a correlation with initial clinical staging with 3.6 to 8.0 times more conversions in patients with Stage II or III disease than in those with Stage I disease. It appears that the majority of metastases to the bone become apparent within the first years. This observation deserves further study to elaborate the natural history of metastatic carcinoma of the breast.

Entities:  

Mesh:

Year:  1978        PMID: 213852

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


  6 in total

1.  Clinical surveillance for early stage breast cancer: an analysis of claims data.

Authors:  M S Simon; M Stano; R K Severson; M S Hoff; D W Smith
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

2.  An analysis of the cost of clinical surveillance after primary therapy for women with early stage invasive breast cancer.

Authors:  M S Simon; M Stano; M Hussein; M Hoff; D Smith
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

3.  Baseline staging tests in primary breast cancer: a practice guideline.

Authors:  R E Myers; M Johnston; K Pritchard; M Levine; T Oliver
Journal:  CMAJ       Date:  2001-05-15       Impact factor: 8.262

4.  Breast cancer surveillance--a cost-effective strategy.

Authors:  D V Schapira
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

5.  An evaluation of clinical follow-up in women with early stage breast cancer among physician members of the American Society of Clinical Oncology.

Authors:  M S Simon; M Hoff; M Hussein; S Martino; A Walt
Journal:  Breast Cancer Res Treat       Date:  1993-09       Impact factor: 4.872

6.  CA15-3: a reliable indicator of metastatic bone disease in breast cancer patients.

Authors:  D P O'Brien; P G Horgan; D B Gough; R Skehill; H Grimes; H F Given
Journal:  Ann R Coll Surg Engl       Date:  1992-01       Impact factor: 1.891

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.